RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • The efficacy and safety of canagliflozin across racial groups in patients with type 2 diabetes mellitus.

The efficacy and safety of canagliflozin across racial groups in patients with type 2 diabetes mellitus.

Add to Collection
2015 Others Fist_Author_Year_PM

Full Author : ['Gavin, James R 3rd', 'Davies, Melanie J', 'Davies, Michael', 'Vijapurkar, Ujjwala', 'Alba, Maria', 'Meininger, Gary']
Journal Title : Current medical research and opinion
Chapter : Section3
Journal Year : 2015
Cited by : Not Available

OBJECTIVE: Canagliflozin, a sodium-glucose co-transporter 2 inhibitor, enhances urinary glucose excretion through an insulin-independent mode of action, and improves glycemic control in patients with type 2 diabetes mellitus (T2DM). This study assessed th.....

Keywords : ["canagliflozin across racial group", "type diabetes mellitus", "safety", "patient", "efficacy"]